Veliparib with carboplatin and paclitaxel in BRCA-mutated advanced breast cancer (BROCADE3): Final overall survival results from a randomized phase 3 trial
Véronique Dièras, Hyo S. Han, Hans Wildiers, Michael Friedländer, Jean-Pierre Ayoub, Shannon L. Puhalla, Delphine Loirat, Christine K. Ratajczak, Hephzibah Adamu, Vincent Girardi, Banu Arun
Topics & Concepts
VeliparibCarboplatinPaclitaxelMedicineOncologyInternal medicineBreast cancerChemotherapyCancerBiologyCisplatinGeneticsPolymerasePoly ADP ribose polymeraseGenePARP inhibition in cancer therapyCancer Treatment and PharmacologyAdvanced Breast Cancer Therapies